Here's what Cadila has to say about US price erosion concerns

The Indian Pharmaceutical Alliance's (IPA) quality forum is currently underway in Hyderbad. CNBC-TV18’s Arachana Shukla caught up with the Managing Director of Cadila Healthcare, Sharvil Patel on the sidelines of that forum and asked him about price erosion in the US market.

With the consolidation that has been happening in the US, there has been significant challenges on the pricing front. Also, with the approval cycles improving faster, you will see far more approvals coming through in the US. What is very important is to have a portfolio of high volume products, portfolio of some differentiated products where you can see limited competition, he said.

For more, watch accompanying video…